Chest Pain  >>  Integrilin (eptifibatide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Integrilin (eptifibatide) / Takeda
TAO, NCT01076764 / 2009-016568-36: Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

Checkmark Moderate-to-high risk non-ST-elevation ACS (TAO study)
Sep 2013 - Sep 2013: Moderate-to-high risk non-ST-elevation ACS (TAO study)
Checkmark In pts with non-ST-elevation ACS
Jun 2013 - Jun 2013: In pts with non-ST-elevation ACS
Completed
3
13220
Europe, Canada, US, RoW
Otamixaban, XRP0673, Placebo (for Otamixaban), UFH, Unfractionated Heparin, Placebo (for UFH), Eptifibatide, Placebo (for Eptifibatide)
Sanofi
Acute Coronary Syndrome
05/13
05/13

Download Options